Crossmark

Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies

Crossref DOI link: https://doi.org/10.1186/s13550-015-0142-y

Published Online: 2015-11-09

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bison, Sander M.

Haeck, Joost C.

Bol, K.

Koelewijn, S. J.

Groen, H. C.

Melis, M.

Veenland, J. F.

Bernsen, M. R.

de Jong, M.
Funding

Funding for this research was provided by:

Erasmus Medisch Centrum (NL) (R 2008-4037)
License Information

License valid from 2015-11-09